(Q45377896)

English

A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study

scientific article published on 21 February 2013

Statements

A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study (English)
21 February 2013
214-222

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit